Table 1.
MICs for evaluated isolatesa
Isolate | MICs (μg/ml) |
||
---|---|---|---|
DAP | SXT | VAN | |
SA H9749-1 | 4 | 0.03/0.6 | 8–16 |
R6212 | 4 | 0.06/1.19 | 2 |
R5599 | 2 | 0.06/1.19 | 1 |
R5563 | 2 | 0.03/0.6 | 2 |
DAP, daptomycin; SXT, trimethoprim-sulfamethoxazole; VAN, vancomycin.
MICs for evaluated isolatesa
Isolate | MICs (μg/ml) |
||
---|---|---|---|
DAP | SXT | VAN | |
SA H9749-1 | 4 | 0.03/0.6 | 8–16 |
R6212 | 4 | 0.06/1.19 | 2 |
R5599 | 2 | 0.06/1.19 | 1 |
R5563 | 2 | 0.03/0.6 | 2 |
DAP, daptomycin; SXT, trimethoprim-sulfamethoxazole; VAN, vancomycin.